US Patent 9550755 Complement pathway modulators and uses thereof
Patent 9550755 was granted and assigned to Novartis on January, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 27, 2013
Date of Patent
January 24, 2017
Patent Applicant
Patent Application Number
14409914
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9550755 Complement pathway modulators and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
